Insulet had two patents in mobile during Q2 2024. Insulet Corp has developed an on-body medicament delivery system for type 2 diabetes patients that automatically adjusts basal delivery based on glucose level readings. This system can receive glucose levels wirelessly from a sensor or manually entered by the patient, allowing for personalized medicament titration. GlobalData’s report on Insulet gives a 360-degree view of the company including its patenting strategy. Buy the report here.
Smarter leaders trust GlobalData
Insulet had no grants in mobile as a theme in Q2 2024.
Recent Patents
Application: Programmatic medicament titration with a medicament delivery device (Patent ID: US20240148971A1)
Insulet Corp. has developed an on-body medicament delivery system for type 2 diabetes patients that automatically performs medicament titration based on glucose level readings. The system adjusts the basal medicament delivery rate/dose by receiving glucose level readings wirelessly from a glucose sensor or manually entered by the patient into a management device. The adjustments are made by a programmatic mechanism, such as computer programming instructions executing on a processor, to ensure optimal delivery of the medicament.
The patent claims detail a medicament delivery device that establishes an initial basal medicament delivery rate for a type 2 diabetes patient and adjusts it based on received glucose level readings. The device can receive input regarding patient characteristics and titration frequency to personalize the delivery rate. Additionally, a management device is provided to facilitate input collection and communication with the medicament delivery device. The system can also adjust the delivery rate based on factors like patient activity, sleep, and time of day, ensuring effective and personalized medicament delivery for improved glucose control in type 2 diabetes patients.
To know more about GlobalData’s detailed insights on Insulet, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies across the world’s largest industries.
